GJA1 and non-small cell lung carcinoma: In pancreatic cancer, the loss of Cx43 expression promotes chemotherapy resistance (105), whereas in non-small cell lung cancer (NSCLC), low expression of Cx43 results in cisplatin resistance, which can be reversed by Artemisinin B (Art B) through upregulation of Cx43 (19).